Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib in children with recurrent CNS tumors
NCT02255461Phase 1Terminated
- Sponsor
- Pediatric Brain Tumor Consortium
- Start
- Dec 2014
- Primary completion
- Feb 2019
- Countries
- 1
01
Overview
Phase 1, open-label trial of palbociclib in central nervous system tumor, sponsored by Pediatric Brain Tumor Consortium. Started Dec 2014; status: terminated.
02
Drugs
palbociclib
03
Conditions
central nervous system tumor
Beyond the preview
Go deeper on NCT02255461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02255461.